Thermo Fisher Scientific Inc (NYSE:TMO)

CAPS Rating: 4 out of 5

The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics to make the world healthier, cleaner and safer.

Results 1 - 20 of 60 : 1 2 3 Next »

Recs

0
Member Avatar otherAquanaut (99.81) Submitted: 1/31/2014 10:24:13 AM : Outperform Start Price: $114.16 TMO Score: -5.67

Pressing down the cost of genetic sequencing. That's a huge forward looking market.

Recs

0
Member Avatar BYUofU (40.60) Submitted: 9/20/2013 12:00:20 PM : Underperform Start Price: $93.37 TMO Score: -15.16

Insider selling

Recs

0
Member Avatar tomd728 (26.47) Submitted: 5/31/2013 12:43:52 AM : Outperform Start Price: $87.79 TMO Score: +19.46

Latest acquisition was enormous and accretive this year.All of product line absolutely necessary in measurement and testing

Recs

0
Member Avatar unets1 (< 20) Submitted: 8/21/2012 5:28:20 PM : Outperform Start Price: $55.35 TMO Score: +83.45

Largest supplier in the Lab instrumentsfor Bio and pharma drug development area with very good positioning and a consolidator.

Recs

0
Member Avatar SotaiR (47.28) Submitted: 5/24/2012 10:42:46 PM : Outperform Start Price: $51.05 TMO Score: +92.95

As an employee I can say things are good at Thermo Fisher Scientific. The roll out of Unity Lab Services has given the company a unique position in the asset management/services sector to add to their competitive catalog and their outstanding brands of instruments (Thermo) and lab supplies (Fisher). This new brand (Unity) will position them to corner the market even more. Keep your eyes on this stock, safe bet, great management and great people.

Recs

0
Member Avatar bradford86 (99.72) Submitted: 1/14/2012 12:24:01 PM : Outperform Start Price: $48.67 TMO Score: +102.28

273. Thermo Fisher Scientific (NYSE: TMO) has a history of beating their consensus expectations. Their P/E at present looks high but you need to back the outperformance of one quarter last year. Their P/E really is about 10. That's cheap considering that even analyst bearish cases forecast top line revenue growth and EPS estimates holding the line, so to speak. I think that the present valuation is pricing in the analyst worst case scenerio. There is upside here and I think that this one got beat up by tax loss selling last year and the swing up that you've seen so far this year is simply the January effect. Is there more to this beyond just an effect? I think so. Target: $52-$57.

http://beta.fool.com/bradford86/2012/01/13/price-market-part-41/

Recs

0
Member Avatar Lisinvestment (73.00) Submitted: 1/6/2012 10:07:36 PM : Outperform Start Price: $45.59 TMO Score: +117.71

This is tracking porfortlio of the 20 stock I pick for 2012...

Recs

0
Member Avatar jimif79 (< 20) Submitted: 11/12/2011 11:29:30 AM : Outperform Start Price: $47.67 TMO Score: +102.90

Based on the 5-yr. weighted average of p/e, p/b, p/s, roe, roa the fair value of the company is $57.74. Right now they are trading near their 52 week low since they haven't quite rebounded from the August collapse. Only see an upside to this stock.

Recs

0
Member Avatar motame98 (29.18) Submitted: 8/9/2011 5:21:23 PM : Outperform Start Price: $49.93 TMO Score: +75.05

EBITA continues to grow. Supplier for large scientifically community.

Recs

0
Member Avatar stovkey1highdiv (36.00) Submitted: 5/4/2011 9:36:48 AM : Outperform Start Price: $59.31 TMO Score: +61.46

key03, no div

Recs

0
Member Avatar RINDER (< 20) Submitted: 9/15/2010 12:21:49 PM : Outperform Start Price: $45.80 TMO Score: +94.27

Over reaction down ... good company ... back to 55

Recs

0
Member Avatar Bigstu52 (71.31) Submitted: 9/5/2010 4:48:17 PM : Outperform Start Price: $43.91 TMO Score: +101.99

http://research2.fidelity.com/fidelity/research/reports/pdf/getReport.asp?feedID=72&docTag=88355610&verstionTag=3J25FEJLT21UJH8VDDPKDDDDBJ&user_sessionid=AD0BCA9F0BE477126D4D0B2F3E17AB1F

Recs

0
Member Avatar lytri (75.36) Submitted: 7/28/2010 11:28:40 AM : Outperform Start Price: $45.35 TMO Score: +94.13

A small adjustment in guidance (.5%) caused an 8% drop. The company still has great fundamentals and this is a good time to buy it at a value price.

Recs

0
Member Avatar metageek (49.65) Submitted: 6/4/2010 11:37:28 PM : Outperform Start Price: $48.79 TMO Score: +67.40

I work here

Recs

0
Member Avatar rusman1984 (72.55) Submitted: 2/4/2010 7:00:14 PM : Outperform Start Price: $46.17 TMO Score: +81.13

Thermo-Fisher is the giant of scientific supply companies. If they can manage all the acquisitions from the past couple of years including the attempt to corner the market of siRNA products. Im bullish because of the nice margins they get from so many great suppliers like 5'Prime, GE Healthcare, and BrandTek.

Recs

2
Member Avatar SenseA (< 20) Submitted: 10/16/2009 12:33:08 PM : Outperform Start Price: $46.29 TMO Score: +84.04

My father worked for this company for a long time as a regional accountant. The management is very intelligent. The company is great top to bottom. My family has over 650 shares invested long term because we know first had the credibility and culture of the company.

Recs

0
Member Avatar RedDave (25.74) Submitted: 10/10/2009 10:11:12 PM : Outperform Start Price: $44.53 TMO Score: +93.48

Massive repurchase of stock during the first quarter of this year.

Recs

1
Member Avatar gojoe2 (< 20) Submitted: 9/24/2009 10:34:12 AM : Outperform Start Price: $44.06 TMO Score: +92.13

The world future depends on creative minds. Thermo has more than it's share. I just believe you can hang your hat on this company and keep it long term. It is dominate in all of the growth areas. As the company matures there will probably be a dividend but don't rush it. I will hold long term. gojoe2

Recs

0
Member Avatar TheGouch23 (51.95) Submitted: 7/16/2009 1:47:09 PM : Outperform Start Price: $39.62 TMO Score: +100.16

With healthcare and the environment becoming increasingly popular topics (and growth projected in both), a company like TMO which has a hand in them will surely benefit. As creative minds leave finance and begin to drift towards sciences, it's reasonable to expect growth in real US innovation again (rather than the financial trickery and smoke-and-mirrors-"creativity" that led to this recession). Smart minds will have green collar jobs, and jobs in healthcare, and they will need instruments to their jobs. This bodes well for TMO's profits and prospects for growing market presence.

Recs

0
Member Avatar JjcampNR (75.70) Submitted: 6/17/2009 10:44:48 PM : Outperform Start Price: $40.05 TMO Score: +89.27

Those who supply the new bio-techs, pharmas, and life science companies will succeed along with them, but with less volatility.

Results 1 - 20 of 60 : 1 2 3 Next »

Featured Broker Partners


Advertisement